Guo-Liang Yu
Chief Executive Officer at APOLLOMICS, INC.
Net worth: 6 M $ as of 2024-03-30
Profile
Guo-Liang Yu is the founder of QuanDx, Inc. (2012), Epitomics, Inc. (2001), and Apollomics, Inc. (United States) (2015).
He is also the founder of NVIGEN, Inc., The Chinese Biopharmaceutical Association, Immune-Onc Therapeutics, Inc., and Innoforce Pharmaceuticals Co. Ltd.
Dr. Yu's current job(s) include Chairman & Chief Executive Officer at Apollomics, Inc., Chairman at The BayHelix Group, and Chairman at Zhejiang Crownmab Biotech Co. Ltd.
He is also a Director at the University of the Pacific, National Foundation for Cancer Research, The Chinese-American Biopharmaceutical Society, Alpine BioTherapeutics Corp., Maijin Biomedical Technology (Shanghai) Co., Ltd., Zhejiang Innoforce Pharmaceuticals Co., Ltd., and OrbiMed Advisors Private Equity.
Dr. Yu's former job(s) include Executive Chairman & Chief Technology Officer at Crown Bioscience, Inc., Chairman & Chief Technology Officer at Crown Bioscience International (2013-2018), Chairman at Qyuns Therapeutics Co., Ltd.
(2015), Director at Applied StemCell, Inc., Director at Ray Wu Memorial Fund (2013-2015), Independent Director at PlexBio Co., Ltd.
(2018-2020), Senior Scientist at Human Genome Sciences, Inc., and Senior Vice President-Research & Development at Mendel Biotechnology, Inc. Dr. Yu's education includes a doctorate degree from the University of California, Berkeley (1990) and an undergraduate degree from Fudan University (1984).
Dr. Yu is also the founder of NVIGEN, Inc., The Chinese Biopharmaceutical Association, Immune-Onc Therapeutics, Inc., Innoforce Pharmaceuticals Co. Ltd...
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
APOLLOMICS INC. CLASS A
8.56% | 2023-09-28 | 7,660,118 ( 8.56% ) | 6 M $ | 2024-03-30 |
Guo-Liang Yu active positions
| Companies | Position | Start |
|---|---|---|
| APOLLOMICS, INC. | Chief Executive Officer | 2023-03-29 |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Founder | - |
Zhejiang Innoforce Pharmaceuticals Co., Ltd.
 Zhejiang Innoforce Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Innoforce Pharmaceuticals Co., Ltd. is a Chinese company that specializes in enabling the innovation and supply of RNA, plasmid DNA, cell and gene therapeutics. The private company is based in Hangzhou, China. The company has a world-class manufacturing and development hub that provides CDMO services. | Director/Board Member | - |
Innoforce Pharmaceuticals Co. Ltd.
 Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023. | Founder | 2017-12-31 |
Maijin Biomedical Technology (Shanghai) Co., Ltd.
 Maijin Biomedical Technology (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Maijin Biomedical Technology (Shanghai) Co. Ltd. provides immunology-related therapeutic areas in China. The company is headquartered in Shanghai, China. | Director/Board Member | 2020-02-29 |
| Zhejiang Crownmab Biotech Co. Ltd. | Chairman | 2018-05-28 |
Alpine BioTherapeutics Corp.
 Alpine BioTherapeutics Corp. BiotechnologyHealth Technology Alpine BioTherapeutics Corp. engages in the development of stem cell-based therapy to treat blindness. The company was founded by Jiagang Zhao and Ying Wu in 2017 and is headquartered in San Diego, CA. | Director/Board Member | - |
NVIGEN, Inc.
 NVIGEN, Inc. Medical SpecialtiesHealth Technology NVIGEN, Inc. develops multifunctional and biodegradable nanoparticles. Its products include MagVigen, MaxVigen, MyQuVigen, and AuVigen. The company was founded by Aihua Fu and Guo Liang Yu and is headquartered in Campbell, CA. | Founder | - |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Chief Executive Officer | 2018-08-15 |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Former positions of Guo-Liang Yu
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
Training of Guo-Liang Yu
| University of California, Berkeley | Doctorate Degree |
| Fudan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PLEXBIO CO., LTD. | Health Technology |
| QYUNS THERAPEUTICS CO., LTD. | Health Technology |
| APOLLOMICS, INC. | Health Technology |
| Private companies | 21 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Health Technology |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Applied StemCell, Inc.
 Applied StemCell, Inc. BiotechnologyHealth Technology Applied StemCell, Inc. is a biotechnology company. Its products include stem cell research, genome editing products for cell line generation, primary cells from patient samples and isogenic cell lines. The company was founded by Ruhong Jiang, Ruby Yanru Chen-Tsai and Michael Cleary and is headquartered in Milpitas, CA. | Health Technology |
NVIGEN, Inc.
NVIGEN, Inc. Medical SpecialtiesHealth Technology NVIGEN, Inc. develops multifunctional and biodegradable nanoparticles. Its products include MagVigen, MaxVigen, MyQuVigen, and AuVigen. The company was founded by Aihua Fu and Guo Liang Yu and is headquartered in Campbell, CA. | Health Technology |
QuanDx, Inc.
 QuanDx, Inc. Medical SpecialtiesHealth Technology QuanDx, Inc. provides molecular diagnostics. It specializes in the development and commercialization of novel diagnostic tools. The firm provides diagnostic and prognostic information for hematological and solid tumor cancers, as well as a number of infectious diseases. The company was founded by Matthew Lei and Guo-Liang Yu in 2012 and is headquartered in San Jose, CA. | Health Technology |
Mendel Biotechnology, Inc.
 Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA. | Commercial Services |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Finance |
National Foundation for Cancer Research
 National Foundation for Cancer Research Miscellaneous Commercial ServicesCommercial Services The National Foundation for Cancer Research is a non-profit organization that provides funding to scientists for cancer research. The non-profit company is based in Bethesda, MD. The company's mission is to support life-saving discoveries for cancer patients. | Commercial Services |
| The BayHelix Group | |
| The Chinese Biopharmaceutical Association | |
The Chinese-American Biopharmaceutical Society
 The Chinese-American Biopharmaceutical Society Pharmaceuticals: MajorHealth Technology The Chinese-American Biopharmaceutical Society is a non-profit organization for professionals in the biopharmaceutical industry. The non-profit company is based in San Francisco, CA, the birthplace of biotechnology and one of the largest biomedical hubs in the world. The company's membership consists of life science professionals from a broad range of experience levels, with a large percentage of members holding senior or executive positions in the industry. The society offers year-round sponsorship opportunities, including the highly anticipated 2023 annual BioPacific Conference, and leverages an extensive network of life sciences professionals. | Health Technology |
| Ray Wu Memorial Fund | |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Health Technology |
| Zhejiang Crownmab Biotech Co. Ltd. | |
Alpine BioTherapeutics Corp.
Alpine BioTherapeutics Corp. BiotechnologyHealth Technology Alpine BioTherapeutics Corp. engages in the development of stem cell-based therapy to treat blindness. The company was founded by Jiagang Zhao and Ying Wu in 2017 and is headquartered in San Diego, CA. | Health Technology |
Maijin Biomedical Technology (Shanghai) Co., Ltd.
Maijin Biomedical Technology (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Maijin Biomedical Technology (Shanghai) Co. Ltd. provides immunology-related therapeutic areas in China. The company is headquartered in Shanghai, China. | Commercial Services |
Zhejiang Innoforce Pharmaceuticals Co., Ltd.
Zhejiang Innoforce Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Innoforce Pharmaceuticals Co., Ltd. is a Chinese company that specializes in enabling the innovation and supply of RNA, plasmid DNA, cell and gene therapeutics. The private company is based in Hangzhou, China. The company has a world-class manufacturing and development hub that provides CDMO services. | Health Technology |
Innoforce Pharmaceuticals Co. Ltd.
Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023. | Health Technology |
- Stock Market
- Insiders
- Guo-Liang Yu
